Rockwell Medical Q2 FY26 net loss narrows 20% to USD 1.2 million; net sales rise 11% to USD 17.8 million

Reuters2026/08/13 10:01

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Rockwell Medical posted Q2 net sales of USD 17.8 million, up 11% year over year.
Net loss narrowed to USD 1.2 million; gross margin rose 2 percentage points to 18%.
Adjusted EBITDA loss under non-GAAP held at USD 0.2 million.
Cash, cash equivalents, and available-for-sale investments totaled USD 24.8 million at June 30.
Reiterated 2026 outlook: net sales USD 70 million-USD 75 million; adjusted EBITDA USD 1 million-USD 2 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rockwell Medical Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260813588314) on August 13, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Rockwell Medical Q2 FY26 net loss narrows 20% to USD 1.2 million; net sales rise 11% to USD 17.8 million

You may also like

Crypto prices